Dolastatin-10 derivative, method of producing the same and anticancer drug composition containing the same
US9278996B2 · kind B2 · utility
1Cited by
3References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 16, 2013 |
| Grant date | Mar 8, 2016 |
| Priority date | — |
| Expiry date | Sep 16, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a dolastatin-10 derivative having excellent anticancer activity, a method of producing the same and anticancer drug composition containing the same as an active ingredient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.